M
Marine Diviné
Researcher at University of Paris
Publications - 3
Citations - 543
Marine Diviné is an academic researcher from University of Paris. The author has contributed to research in topics: Acquired immune system & Survival rate. The author has an hindex of 3, co-authored 3 publications receiving 506 citations.
Papers
More filters
Journal ArticleDOI
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease
Christophe Fermé,Houchingue Eghbali,J.H. Meerwaldt,Chantal Rieux,Jacques Bosq,Françoise Berger,Theodore Girinsky,Pauline Brice,Mars B. van't Veer,Jan Walewski,Pierre Lederlin,Umberto Tirelli,Patrice Carde,Eric Van Den Neste,Emmanuel Gyan,Mathieu Monconduit,Marine Diviné,John M. M. Raemaekers,Gilles Salles,Evert M. Noordijk,Geert Jan Creemers,Jean Gabarre,Anton Hagenbeek,Oumedaly Reman,Michel Blanc,José Thomas,B. Vie,Johanna Kluin-Nelemans,Fernando Viseu,Joke W. Baars,Philip Poortmans,Pieternella J. Lugtenburg,Christian Carrie,Jérôme Jaubert,Michel Henry-Amar +34 more
TL;DR: Chemotherapy plus involved-field radiotherapy should be the standard treatment for Hodgkin's disease with favorable prognostic features and in patients with unfavorable features, four courses of chemotherapyplus involved- field radiotherapy ought to be thestandard treatment.
Journal ArticleDOI
First results of the EORTC-GELA H9 randomized trials: the H9-F trial (comparing 3 radiation dose levels) and H9-U trial (comparing 3 chemotherapy schemes) in patients with favorable or unfavorable early stage Hodgkin’s lymphoma (HL)
Evert M. Noordijk,J. Thomas,Christophe Fermé,M. B. Van't Veer,Pauline Brice,Marine Diviné,F. Morschhauser,Patrice Carde,H. Eghbali,Michel Henry-Amar +9 more
TL;DR: The aim of EORTC and GELA is to reducing acute and late side effects of treatment in early stages HL, without jeopardizing high event-free survival (EFS) and overall survival (OS) rates already achieved.
Journal ArticleDOI
Severe decrease in peripheral blood dendritic cells in hairy cell leukaemia.
Anne Bourguin-Plonquet,Hélène Rouard,Françoise Roudot-Thoraval,Coralie Bellanger,Jeanine Marquet,Marie-Hélène Delfau-Larue,Marine Diviné,Jean-Pierre Farcet +7 more
TL;DR: The decrease in dendritic cells in hairy cell leukaemia suggests that defective antigen presentation could affect susceptibility to intracellular pathogens in HCL.